CLINICAL_TRIALS
trial_result
· 2023-04-18
Clinical Trial Update: Trial to Evaluate CIS43LS in Healthy Adults [Phase 1]
Summary
Phase 1 trial evaluating CIS43LS in healthy adults for malaria has completed; results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2023-04-18